Norway withdrew pholcodine from the market in 2007 .
The prevalence of anti-suxamethonium antibodies fell by over 80 % in two years .
Norway withdrew pholcodine from the market in 2007 , and the prevalence of anti-suxamethonium antibodies fell by over 80 % in two years .